{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:28:17Z","timestamp":1792510097578,"version":"4.5.0"},"reference-count":234,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Salivary gland-type tumors of the lung are thought to originate from the submucosal exocrine glands of the large airways. Due to their rare occurrence, reports of their study are limited to small-scale or case reports. Therefore, daily clinical practices often require a search for previous reports. In the last 20\u00a0years, several genetic rearrangements have been identified, such as MYB::NF1B rearrangements in adenoid cystic carcinoma, CRTC1::MAML2 rearrangements in mucoepidermoid carcinoma, EWSR1::ATF1 rearrangements in hyalinizing clear cell carcinoma and rearrangements of the EWSR1 locus or FUS (TLS) locus in myoepithelioma and myoepithelial carcinoma. These molecular alterations have been useful in diagnosing these tumors, although they have not yet been linked to molecularly targeted therapies. The morphologic, immunophenotypic, and molecular characteristics of these tumors are similar to those of their counterparts of extrapulmonary origin, so clinical and radiologic differential diagnosis is required to distinguish between primary and metastatic disease of other primary sites. However, these molecular alterations can be useful in differentiating them from other primary lung cancer histologic types. The management of these tumors requires broad knowledge of the latest diagnostics, surgery, radiotherapy, bronchoscopic interventions, chemotherapy, immunotherapy as well as therapeutic agents in development, including molecularly targeted agents. This review provides a comprehensive overview of the current diagnosis and treatment of pulmonary salivary gland tumors, with a focus on adenoid cystic carcinoma and mucoepidermoid carcinoma, which are the two most common subtypes.<\/jats:p>","DOI":"10.1093\/jjco\/hyad160","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T11:11:30Z","timestamp":1701256290000},"page":"229-247","source":"Crossref","is-referenced-by-count":17,"title":["Current diagnosis and treatment of salivary gland-type tumors of the lung"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4661-6399","authenticated-orcid":false,"given":"Yoshitsugu","family":"Horio","sequence":"first","affiliation":[{"name":"Department of Outpatient Services, Aichi Cancer Center Hospital , Nagoya , Japan"},{"name":"Department of Thoracic Oncology, Aichi Cancer Center Hospital , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Aichi Cancer Center Hospital , Nagoya , Japan"},{"name":"Department of Thoracic Surgery, Teikyo University Hospital , Mizonokuchi, Kanagawa-prefecture , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Masago","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Aichi Cancer Center Hospital , Nagoya , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"2024031106211436500_ref1","first-page":"106","article-title":"Primary salivary gland-type tumors of the lung","volume":"12","author":"Moran","year":"1995","journal-title":"Semin Diagn Pathol"},{"key":"2024031106211436500_ref2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y","article-title":"Lung cancer","volume":"75","author":"Travis","year":"1995","journal-title":"Cancer"},{"key":"2024031106211436500_ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jtho.2023.01.088","article-title":"IASLC lung cancer staging project: the new database to inform revisions in the ninth edition of the TNM classification of lung cancer","volume":"18","author":"Asamura","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2024031106211436500_ref4","volume-title":"Thoracic Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref5","volume-title":"Head and Neck Tumours","author":"Skalova","year":"2022","edition":"5th"},{"key":"2024031106211436500_ref6","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.3390\/cancers14194668","article-title":"The clinical and prognostic characteristics of primary salivary gland-type carcinoma in the lung: a population-based study","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024031106211436500_ref7","doi-asserted-by":"crossref","DOI":"10.1148\/rg.230045","article-title":"Malignant and benign tracheobronchial neoplasms: comprehensive review with radiologic, bronchoscopic, and pathologic correlation","volume":"43","author":"Girvin","year":"2023","journal-title":"Radiographics"},{"key":"2024031106211436500_ref8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(05)70541-6","article-title":"Primary tracheal tumours","volume":"7","author":"Macchiarini","year":"2006","journal-title":"Lancet Oncol"},{"key":"2024031106211436500_ref9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.athoracsur.2006.01.065","article-title":"Uncommon primary tracheal tumors","volume":"82","author":"Gaissert","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2024031106211436500_ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.21037\/acs.2018.02.01","article-title":"Secondary tracheal tumors: a systematic review","volume":"7","author":"Madariaga","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2024031106211436500_ref11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02841860310018053","article-title":"Endobronchial metastases from extrapulmonary solid tumors","volume":"43","author":"S\u00f8rensen","year":"2004","journal-title":"Acta Oncol"},{"key":"2024031106211436500_ref12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.5858\/arpa.2021-0093-RA","article-title":"Salivary gland-type tumors of the lung","volume":"145","author":"Wang","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"2024031106211436500_ref13","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-023-01354-4","article-title":"Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review","volume":"18","author":"Chen","year":"2023","journal-title":"Diagn Pathol"},{"key":"2024031106211436500_ref14","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.3390\/ijms241411370","article-title":"Molecular biology and therapeutic targets of primitive tracheal tumors: focus on tumors derived by salivary glands and squamous cell carcinoma","volume":"24","author":"Marchioni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024031106211436500_ref15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.21873\/cdp.10233","article-title":"Mutational signatures in salivary gland carcinomas","volume":"3","author":"Chrysovergis","year":"2023","journal-title":"Cancer Diagn Progn"},{"key":"2024031106211436500_ref16","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/cncr.23048","article-title":"Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors","volume":"110","author":"Molina","year":"2007","journal-title":"Cancer"},{"key":"2024031106211436500_ref17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.crad.2021.09.012","article-title":"Imaging of therapeutic airway interventions in thoracic oncology","volume":"77","author":"Godoy","year":"2022","journal-title":"Clin Radiol"},{"key":"2024031106211436500_ref18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/acs.2018.03.04","article-title":"Overview of malignant tracheal tumors","volume":"7","author":"Madariaga","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2024031106211436500_ref19","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2169\/internalmedicine.1142-22","article-title":"Successful treatment with definitive concurrent chemoradiotherapy followed by durvalumab maintenance therapy in a patient with tracheal adenoid cystic carcinoma: a case report","volume":"62","author":"Mikami","year":"2023","journal-title":"Intern Med"},{"key":"2024031106211436500_ref20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MCP.0000000000000181","article-title":"Malignant tracheal tumors: a review of current diagnostic and management strategies","volume":"21","author":"Sherani","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2024031106211436500_ref21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.rmed.2013.03.017","article-title":"The \u201cforgotten zone\u201d: acquired disorders of the trachea in adults","volume":"107","author":"Al-Qadi","year":"2013","journal-title":"Respir Med"},{"key":"2024031106211436500_ref22","first-page":"378","article-title":"End-inspiratory flow reduction in the forced flow-volume curve as a sign of unilateral bronchial disease","volume":"28","author":"Roos","year":"1985","journal-title":"Neth J Med"},{"key":"2024031106211436500_ref23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/thx.45.8.637","article-title":"The biphasic spirogram: a clue to unilateral narrowing of a mainstem bronchus","volume":"45","author":"Gascoigne","year":"1990","journal-title":"Thorax"},{"key":"2024031106211436500_ref24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3342\/ceo.2015.8.2.161","article-title":"Changes in the flow-volume curve according to the degree of stenosis in patients with unilateral main bronchial stenosis","volume":"8","author":"Ko","year":"2015","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"2024031106211436500_ref25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/j.cpradiol.2019.04.003","article-title":"Tracheobronchial tumors: radiologic-pathologic correlation of tumors and mimics","volume":"49","author":"Bedayat","year":"2020","journal-title":"Curr Probl Diagn Radiol"},{"key":"2024031106211436500_ref26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/rg.291085126","article-title":"Tumors in the tracheobronchial tree: CT and FDG PET features","volume":"29","author":"Park","year":"2009","journal-title":"Radiographics"},{"key":"2024031106211436500_ref27","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/cancers14153585","article-title":"PSMA PET imaging and therapy in adenoid cystic carcinoma and other salivary gland cancers: a systematic review","volume":"14","author":"Tan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024031106211436500_ref28","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.21037\/jtd.2016.11.24","article-title":"Tracheobronchial tumors","volume":"8","author":"Stevic","year":"2016","journal-title":"J Thorac Dis"},{"key":"2024031106211436500_ref29","article-title":"Recent developments in the pathology of primary pulmonary salivary gland-type tumours","author":"Naso","year":"2023","journal-title":"Histopathology"},{"key":"2024031106211436500_ref30","first-page":"335","article-title":"Bronchogenic carcinoma; an analysis of 100 autopsy cases","volume":"111","author":"Smetana","year":"1952","journal-title":"Mil Surg"},{"key":"2024031106211436500_ref31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1097-0142(19870915)60:6<1346::AID-CNCR2820600631>3.0.CO;2-0","article-title":"Mucoepidermoid tumors of the lung","volume":"60","author":"Yousem","year":"1987","journal-title":"Cancer"},{"key":"2024031106211436500_ref32","first-page":"121","volume-title":"Thoracic Tumours","author":"Husain","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref33","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1016\/j.jpedsurg.2007.04.031","article-title":"t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma","volume":"42","author":"Serra","year":"2007","journal-title":"J Pediatr Surg"},{"key":"2024031106211436500_ref34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.humpath.2008.11.007","article-title":"Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma","volume":"40","author":"Achcar","year":"2009","journal-title":"Hum Pathol"},{"key":"2024031106211436500_ref35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/modpathol.2012.154","article-title":"Genomic profiles and CRTC1\u2013MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma","volume":"26","author":"Jee","year":"2012","journal-title":"Mod Pathol"},{"key":"2024031106211436500_ref36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00428-017-2104-4","article-title":"Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature","volume":"470","author":"Salem","year":"2017","journal-title":"Virchows Arch"},{"key":"2024031106211436500_ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143169","article-title":"Primary pulmonary mucoepidermoid carcinoma: histopathological and moleculargenetic studies of 26 cases","volume":"10","author":"Huo","year":"2015","journal-title":"PloS One"},{"key":"2024031106211436500_ref38","doi-asserted-by":"crossref","first-page":"9742091","DOI":"10.1155\/2022\/9742091","article-title":"Pulmonary salivary gland tumor, mucoepidermoid carcinoma: a literature review","volume":"2022","author":"Hu","year":"2022","journal-title":"J Oncol"},{"key":"2024031106211436500_ref39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/PAT.0000000000000014","article-title":"CRTC3-MAML2 fusion transcript in a bronchial mucoepidermoid carcinoma","volume":"45","author":"Chan","year":"2013","journal-title":"Pathology"},{"key":"2024031106211436500_ref40","article-title":"Mucoepidermoid carcinoma of the lung harboring MET Exon 14 skipping mutation treated with tepotinib: a case report","volume":"7","author":"Inno","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"2024031106211436500_ref41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-012-1211-5","article-title":"EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma","volume":"138","author":"Yu","year":"2012","journal-title":"J Cancer Research Clin Oncol"},{"key":"2024031106211436500_ref42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.21037\/tcr.2016.06.14","article-title":"Primary tracheobronchial mucoepidermoid carcinoma: prognostic factors and EGFR mutation analysis of 33 cases","volume":"5","author":"Hu","year":"2016","journal-title":"Transl Cancer Res"},{"key":"2024031106211436500_ref43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.lungcan.2009.01.003","article-title":"Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene","volume":"64","author":"O'Neill","year":"2009","journal-title":"Lung Cancer"},{"key":"2024031106211436500_ref44","doi-asserted-by":"crossref","first-page":"djw036","DOI":"10.1093\/jnci\/djw036","article-title":"The conundrum of genetic \u201cDrivers\u201d in benign conditions","volume":"108","author":"Kato","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2024031106211436500_ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc.2017.5","article-title":"Tissue-specific tumorigenesis: context matters","volume":"17","author":"Schneider","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2024031106211436500_ref46","first-page":"519","article-title":"Molecular targets in salivary gland cancers: a comprehensive genomic analysis of 118 mucoepidermoid carcinoma tumors","volume":"11","author":"Bou Zerdan","year":"2023","journal-title":"Biomedicine"},{"key":"2024031106211436500_ref47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139497","article-title":"The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma","volume":"6","author":"Chen","year":"2021","journal-title":"JCI Insight"},{"key":"2024031106211436500_ref48","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.athoracsur.2018.01.055","article-title":"Primary salivary type lung cancers in the national cancer database","volume":"105","author":"Resio","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2024031106211436500_ref49","first-page":"385","article-title":"Ueber ein Cylindrom der Lunge","volume":"27","author":"Heschl","year":"1877","journal-title":"Wien Med Wochenschr"},{"key":"2024031106211436500_ref50","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/000348943604500336","article-title":"Primary adenocystic carcinoma or cylindroma of the trachea","volume":"45","author":"Guttman","year":"1936","journal-title":"Ann Otol Rhin & Laryng"},{"key":"2024031106211436500_ref51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-0142(196101\/02)14:1<161::AID-CNCR2820140120>3.0.CO;2-N","article-title":"Adenomatoid bronchial tumors. A consideration of the carcinoid tumors and the salivary tumors of the bronchial tree","volume":"14","author":"Weiss","year":"1961","journal-title":"Cancer"},{"key":"2024031106211436500_ref52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/1097-0142(195207)5:4<685::AID-CNCR2820050406>3.0.CO;2-9","article-title":"Adenoid cystic carcinoma (cylindroma) of the bronchial tree","volume":"5","author":"Reid","year":"1952","journal-title":"Cancer"},{"key":"2024031106211436500_ref53","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1245\/s10434-022-11590-5","article-title":"Adenoid cystic carcinoma of lobar bronchial origin: 20-year experience at a single institution","volume":"29","author":"Zhao","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2024031106211436500_ref54","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5223(96)70011-9","article-title":"Adenoid cystic carcinoma of the airway: thirty-two-year experience","volume":"112","author":"Maziak","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024031106211436500_ref55","first-page":"117","volume-title":"Thoracic Tumours","author":"Mehrad","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12105-013-0462-z","article-title":"Fusion oncogenes in salivary gland tumors: molecular and clinical consequences","volume":"7","author":"Stenman","year":"2013","journal-title":"Head Neck Pathol"},{"key":"2024031106211436500_ref57","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","article-title":"MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts","volume":"31","author":"Togashi","year":"2018","journal-title":"Mod Pathol"},{"key":"2024031106211436500_ref58","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41379-019-0277-x","article-title":"Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"2024031106211436500_ref59","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024031106211436500_ref60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ng.2643","article-title":"The mutational landscape of adenoid cystic carcinoma","volume":"45","author":"Ho","year":"2013","journal-title":"Nat Genet"},{"key":"2024031106211436500_ref61","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1172\/JCI67201","article-title":"Whole exome sequencing of adenoid cystic carcinoma","volume":"123","author":"Stephens","year":"2013","journal-title":"J Clin Invest"},{"key":"2024031106211436500_ref62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/1078-0432.CCR-15-2867-T","article-title":"Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations","volume":"22","author":"Mitani","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref63","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103745","article-title":"MYB-NFIB fusion transcript in adenoid cystic carcinoma: current state of knowledge and future directions","volume":"176","author":"Wagner","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024031106211436500_ref64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/2159-8290.CD-15-1470","article-title":"Adenoid cystic carcinoma can be driven by MYB or MYBL1 rearrangements: new insights into MYB and tumor biology","volume":"6","author":"Gonda","year":"2016","journal-title":"Cancer Discov"},{"key":"2024031106211436500_ref65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-022-00488-9","article-title":"Structural variations in cancer and the 3D genome","volume":"22","author":"Dubois","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2024031106211436500_ref66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier","year":"2016","journal-title":"Nat Genet"},{"key":"2024031106211436500_ref67","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11864-022-01001-y","article-title":"Metastatic adenoid cystic carcinoma: genomic landscape and emerging treatments","volume":"23","author":"Sousa","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"2024031106211436500_ref68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44178-023-00030-3","article-title":"Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy","volume":"2","author":"Lin","year":"2023","journal-title":"Holistic integrative Oncology"},{"key":"2024031106211436500_ref69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2018.04.020","article-title":"Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival","volume":"121","author":"Xie","year":"2018","journal-title":"Lung Cancer"},{"key":"2024031106211436500_ref70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamaoncol.2016.1790","article-title":"The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform","volume":"3","author":"Morris","year":"2017","journal-title":"JAMA Oncol"},{"key":"2024031106211436500_ref71","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","article-title":"Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets","volume":"27","author":"Ferrarotto","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref72","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/odi.13480","article-title":"Notch activation leads to loss of myoepithelial differentiation and poor outcome in solid adenoid cystic carcinoma","volume":"26","author":"Zhang","year":"2020","journal-title":"Oral Dis"},{"key":"2024031106211436500_ref73","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41388-023-02783-7","article-title":"Genetically engineered mouse models of head and neck cancers","volume":"42","author":"Tasoulas","year":"2023","journal-title":"Oncogene"},{"key":"2024031106211436500_ref74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cam4.1293","article-title":"AKT3 drives adenoid cystic carcinoma development in salivary glands","volume":"7","author":"Zboray","year":"2018","journal-title":"Cancer Med"},{"key":"2024031106211436500_ref75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.pas.0000213314.74423.d8","article-title":"Epithelial-Myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics","volume":"31","author":"Seethala","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00543554","article-title":"\u201cZur Diagnose und Ultrastruktur des tubul\u00e4ren Speichelgang Carcinoms.\u201d Epithelial-Myoepithelial Carcinoma of the Intercalated Ducts","volume":"356","author":"Donath","year":"1972","journal-title":"Virchows Arch A Pathol Pathol Anat"},{"key":"2024031106211436500_ref77","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jcp.46.2.185","article-title":"Epithelial myoepithelial tumour of the tracheal gland","volume":"46","author":"Horinouchi","year":"1993","journal-title":"J Clin Pathol"},{"key":"2024031106211436500_ref78","doi-asserted-by":"crossref","first-page":"4559550","DOI":"10.1155\/2022\/4559550","article-title":"Pulmonary epithelial-myoepithelial carcinoma","volume":"2022","author":"Chen","year":"2022","journal-title":"J Oncol"},{"key":"2024031106211436500_ref79","first-page":"119","volume-title":"Thoracic Tumours","author":"Husain","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12105-013-0506-4","article-title":"HRAS mutations in epithelial-myoepithelial carcinoma","volume":"8","author":"Chiosea","year":"2014","journal-title":"Head Neck Pathol"},{"key":"2024031106211436500_ref81","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0000000000001258","article-title":"Diagnostic significance of HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad histopathologic spectrum","volume":"43","author":"Urano","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref82","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.12998\/wjcc.v8.i23.6026","article-title":"Pleomorphic adenoma of the trachea: a case report and review of the literature","volume":"8","author":"Liao","year":"2020","journal-title":"World J Clin Cases"},{"key":"2024031106211436500_ref83","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00428-020-02810-y","article-title":"Identification of CTNNB1-PLAG1 gene rearrangement in a patient with pulmonary pleomorphic adenoma","volume":"477","author":"Asahina","year":"2020","journal-title":"Virchows Arch"},{"key":"2024031106211436500_ref84","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12890-020-01338-w","article-title":"A case report of bronchial pleomorphic adenoma in a child in China","volume":"20","author":"Zhong","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024031106211436500_ref85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2023.108499","article-title":"Pleomorphic adenoma of the trachea: a case report","volume":"109","author":"Inomata","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"2024031106211436500_ref86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/15513819209024207","article-title":"Pleomorphic adenoma (benign mixed tumor) of the trachea","volume":"12","author":"Heifetz","year":"1992","journal-title":"Pediatr Pathol"},{"key":"2024031106211436500_ref87","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/1097-0142(19940515)73:10<2481::AID-CNCR2820731006>3.0.CO;2-A","article-title":"Benign and malignant salivary gland-type mixed tumors of the lung. Clinicopathologic and immunohistochemical study of eight cases","volume":"73","author":"Moran","year":"1994","journal-title":"Cancer"},{"key":"2024031106211436500_ref88","first-page":"115","volume-title":"Thoracic Tumours","author":"Mehrad","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng0297-170","article-title":"Promoter swapping between the genes for a novel zinc finger protein and \u03b2-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations","volume":"15","author":"Kas","year":"1997","journal-title":"Nat Genet"},{"key":"2024031106211436500_ref90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PAS.0000000000001783","article-title":"HMGA2-WIF1 rearrangements characterize a distinctive subset of salivary pleomorphic adenomas with prominent trabecular (Canalicular Adenoma-like) morphology","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref91","first-page":"1082","article-title":"Myoepithelioma of the lung","volume":"111","author":"Strickler","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"2024031106211436500_ref92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-5002(98)00006-3","article-title":"Myoepithelioma of the lung: report of two cases and review of the literature","volume":"20","author":"Higashiyama","year":"1998","journal-title":"Lung Cancer"},{"key":"2024031106211436500_ref93","first-page":"1","article-title":"So-called mixed tumors of the salivary glands","volume":"35","author":"Sheldon","year":"1943","journal-title":"Arch Pathol"},{"key":"2024031106211436500_ref94","first-page":"242","article-title":"Myoepithelioma of minor salivary gland origin. Light and electron microscopical study","volume":"99","author":"Stromeyer","year":"1975","journal-title":"Arch Pathol"},{"key":"2024031106211436500_ref95","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/PAS.0000000000000560","article-title":"Thoracic myoepithelial tumors: a pathologic and molecular study of 8 cases with review of the literature","volume":"40","author":"Leduc","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAS.0000000000001376","article-title":"Pulmonary myoepithelial tumors with exuberant reactive pneumocytes: proposed reclassification of so-called pneumocytic adenomyoepithelioma","volume":"44","author":"Yuan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref97","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151759","article-title":"Primary high-grade myoepithelial carcinoma of the lung: a study of three cases illustrating frequent SMARCB1-deficiency and review of the literature","volume":"53","author":"Agaimy","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"2024031106211436500_ref98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1159\/000524769","article-title":"Histopathology and cytology of pulmonary myoepithelial neoplasms: 2 cases","volume":"15","author":"Ishikawa","year":"2022","journal-title":"Case Rep Oncol"},{"key":"2024031106211436500_ref99","first-page":"125","volume-title":"Thoracic Tumours","author":"Husain","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref100","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/gcc.20819","article-title":"EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene","volume":"49","author":"Antonescu","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"2024031106211436500_ref101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/gcc.22240","article-title":"Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors","volume":"54","author":"Huang","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"2024031106211436500_ref102","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000478-199401000-00007","article-title":"Hyalinizing clear cell carcinoma of salivary gland","volume":"18","author":"Milchgrub","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref103","first-page":"123","volume-title":"Thoracic Tumours","author":"Husain","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref104","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humpath.2014.11.010","article-title":"Primary pulmonary hyalinizing clear cell carcinoma of bronchial submucosal gland origin","volume":"46","author":"Garc\u00eda","year":"2015","journal-title":"Hum Pathol"},{"key":"2024031106211436500_ref105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/his.12636","article-title":"An uncommon primary lung tumour: hyalinizing clear cell carcinoma, salivary gland-type","volume":"67","author":"Shah","year":"2015","journal-title":"Histopathology"},{"key":"2024031106211436500_ref106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajcp\/aqx048","article-title":"Hyalinizing clear cell carcinoma of the lung: case report and review of the literature","volume":"148","author":"Jeffus","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"2024031106211436500_ref107","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41379-018-0025-7","article-title":"Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas","volume":"31","author":"Takamatsu","year":"2018","journal-title":"Mod Pathol"},{"key":"2024031106211436500_ref108","first-page":"10668969221137516","article-title":"Primary pulmonary hyalinizing clear cell carcinoma: case series with review of literature","volume":"13","author":"Thakur","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"2024031106211436500_ref109","first-page":"509","article-title":"Primary pulmonary hyalinising clear cell carcinoma: two cases and literature review","volume":"44","author":"Di","year":"2022","journal-title":"Malays J Pathol"},{"key":"2024031106211436500_ref110","article-title":"Hyalinising clear cell carcinoma of the lung: a case report and review of literature","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2024031106211436500_ref111","doi-asserted-by":"crossref","first-page":"1175279","DOI":"10.3389\/fonc.2023.1175279","article-title":"Primary pulmonary hyalinizing clear cell carcinoma with fusions of both EWSR1::CREM and IRF2::NTRK3: report of a case with an aggressive behavior","volume":"13","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"2024031106211436500_ref112","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/his.14942","article-title":"Hyalinizing clear cell carcinoma of the lung with EWSR1::CREM fusion","volume":"83","author":"Grosjean","year":"2023","journal-title":"Histopathology"},{"key":"2024031106211436500_ref113","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154237","article-title":"Primary pulmonary hyalinizing clear cell carcinoma with pseudopapillary structures and abundant cysts filled with mucus","volume":"241","author":"Feng","year":"2023","journal-title":"Pathol Res Pract"},{"key":"2024031106211436500_ref114","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gcc.20881","article-title":"EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland","volume":"50","author":"Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"2024031106211436500_ref115","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/PAS.0000000000001114","article-title":"Molecular profiling of hyalinizing clear cell carcinomas revealed a subset of tumors harboring a novel EWSR1-CREM fusion: report of 3 cases","volume":"42","author":"Chapman","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref116","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1097-0142(196911)24:5<1057::AID-CNCR2820240529>3.0.CO;2-L","article-title":"Sialadenoma papilliferum. A previously unreported salivary gland tumor","volume":"24","author":"Abrams","year":"1969","journal-title":"Cancer"},{"key":"2024031106211436500_ref117","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00428-003-0879-y","article-title":"Sialadenoma papilliferum of bronchus","volume":"443","author":"Bobos","year":"2003","journal-title":"Virchows Arch"},{"key":"2024031106211436500_ref118","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/his.14733","article-title":"Pulmonary sialadenoma papilliferum and its mimics: what you need to know","volume":"81","author":"Gao","year":"2022","journal-title":"Histopathology"},{"key":"2024031106211436500_ref119","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pathol.2020.11.012","article-title":"Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma","volume":"53","author":"Sasaki","year":"2021","journal-title":"Pathology"},{"key":"2024031106211436500_ref120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PAS.0000000000001573","article-title":"AKT1 mutations in peripheral bronchiolar papilloma: glandular papilloma and mixed squamous cell and glandular papilloma is distinct from bronchiolar adenoma","volume":"45","author":"Sasaki","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"2024031106211436500_ref121","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153457","article-title":"Differential diagnosis among benign endobronchial papillary tumors with a glandular component","volume":"222","author":"Sasaki","year":"2021","journal-title":"Pathol Res Pract"},{"key":"2024031106211436500_ref122","first-page":"53","volume-title":"Thoracic Tumours","author":"Yoshida","year":"2021","edition":"5th"},{"key":"2024031106211436500_ref123","first-page":"339","article-title":"Bronchial adenomas arising in mucous glands; illustrative case","volume":"29","author":"Ramsey","year":"1953","journal-title":"Am J Pathol"},{"key":"2024031106211436500_ref124","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100182","article-title":"Mucous gland adenoma of the lung: a neoplastic counterpart of mucinous bronchial glands","volume":"36","author":"Sasaki","year":"2023","journal-title":"Mod Pathol"},{"key":"2024031106211436500_ref125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.otohns.2004.05.018","article-title":"Contemporary staging and prognosis for primary tracheal malignancies: a population-based analysis","volume":"131","author":"Bhattacharyya","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2024031106211436500_ref126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-031-21040-2_12","volume-title":"The Thorax: Medical, Radiological, and Pathological Assessment","author":"Sagar","year":"2023","edition":"1st"},{"key":"2024031106211436500_ref127","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0003-4975(89)90380-9","article-title":"Mucoepidermoid lung tumors","volume":"47","author":"Heitmiller","year":"1989","journal-title":"Ann Thorac Surg"},{"key":"2024031106211436500_ref128","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3390\/cancers14102524","article-title":"The role of surgery for oligometastatic non-small cell lung cancer","volume":"14","author":"Euhus","year":"2022","journal-title":"Cancer"},{"key":"2024031106211436500_ref129","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jtho.2023.05.003","article-title":"Local treatments of oligometastatic and oligoprogressive NSCLC should become the standard of care","volume":"18","author":"Videtic","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2024031106211436500_ref130","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3390\/cancers14215339","article-title":"Oligometastatic non-small cell lung cancer: a practical review of prospective trials","volume":"14","author":"Baydoun","year":"2022","journal-title":"Cancer"},{"key":"2024031106211436500_ref131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.thorsurg.2018.01.010","article-title":"Distal tracheal resection and reconstruction: state of the art and lessons learned","volume":"28","author":"Mathisen","year":"2018","journal-title":"Thorac Surg Clin"},{"key":"2024031106211436500_ref132","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.21037\/tlcr-21-731","article-title":"Carinal resection and reconstruction: now and in the future","volume":"10","author":"Matsuura","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"2024031106211436500_ref133","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1002\/hed.25147","article-title":"Unique application of awake tracheoscopy and endobronchial ultrasound in the management of tracheal mucoepidermoid carcinoma","volume":"40","author":"Rehman","year":"2018","journal-title":"Head Neck"},{"key":"2024031106211436500_ref134","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijrobp.2011.12.011","article-title":"The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis","volume":"84","author":"Xie","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024031106211436500_ref135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clon.2017.10.012","article-title":"Radiotherapy for tracheal-bronchial cystic adenoid carcinomas","volume":"30","author":"Levy","year":"2018","journal-title":"Clin Oncol"},{"key":"2024031106211436500_ref136","first-page":"00140","article-title":"Role of radiotherapy in the management of rare solid thoracic tumors of the adults","volume":"S1278-3218","author":"Buchalet","year":"2023","journal-title":"Cancer Radiother"},{"key":"2024031106211436500_ref137","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jtcvs.2022.10.048","article-title":"Retrospective study of outcomes after extended resection for tracheobronchial adenoid cystic carcinoma","volume":"165","author":"Estephan","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024031106211436500_ref138","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1200\/JCO.2007.13.7273","article-title":"Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiation","volume":"25","author":"Allen","year":"2007","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.14338\/IJPT-22-00036.1","article-title":"Radiation therapy for primary adenoid cystic carcinoma of the trachea: photons, protons, or carbon","volume":"9","author":"Tun","year":"2023","journal-title":"Int J Part Ther"},{"key":"2024031106211436500_ref140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s42254-021-00368-5","article-title":"Physics and biomedical challenges of cancer therapy with accelerated heavy ions","volume":"3","author":"Durante","year":"2021","journal-title":"Nat Rev Phys"},{"key":"2024031106211436500_ref141","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13014-019-1323-z","article-title":"Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution","volume":"14","author":"H\u00f6gerle","year":"2019","journal-title":"Radiat Oncol"},{"key":"2024031106211436500_ref142","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12885-021-08493-1","article-title":"Definitive carbon ion radiotherapy for tracheobronchial adenoid cystic carcinoma: a preliminary report","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"2024031106211436500_ref143","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.lungcan.2020.05.016","article-title":"Clinical outcomes and the role of bronchoscopic intervention in patients with primary pulmonary salivary gland-type tumors","volume":"146","author":"Kim","year":"2020","journal-title":"Lung Cancer"},{"key":"2024031106211436500_ref144","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1513\/AnnalsATS.201812-892CME","article-title":"Bronchoscopic ablative therapies for malignant central airway obstruction and peripheral lung tumors","volume":"16","author":"Chaddha","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2024031106211436500_ref145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/resp.13801","article-title":"Airway stenting: technological advancements and its role in interventional pulmonology","volume":"25","author":"Guibert","year":"2020","journal-title":"Respirology"},{"key":"2024031106211436500_ref146","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jjco\/hyac008","article-title":"Systemic therapy for salivary gland malignancy: current status and future perspectives","volume":"52","author":"Imamura","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"2024031106211436500_ref147","doi-asserted-by":"crossref","first-page":"14891","DOI":"10.3390\/ijms232314891","article-title":"The therapeutic landscape of salivary gland malignancies-where are we now?","volume":"23","author":"Cleymaet","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024031106211436500_ref148","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11864-022-01043-2","article-title":"Systemic and targeted therapies in adenoid cystic carcinoma","volume":"24","author":"Kacew","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"2024031106211436500_ref149","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S","article-title":"Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients","volume":"68","author":"Licitra","year":"1991","journal-title":"Cancer"},{"key":"2024031106211436500_ref150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.20327","article-title":"Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group","volume":"28","author":"Gilbert","year":"2006","journal-title":"Head Neck"},{"key":"2024031106211436500_ref151","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.annonc.a010684","article-title":"Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients","volume":"7","author":"Licitra","year":"1996","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref152","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.24745","article-title":"Phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC clinical trials group","volume":"116","author":"Laurie","year":"2010","journal-title":"Cancer"},{"key":"2024031106211436500_ref153","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3109\/00016489.2016.1170876","article-title":"Combination chemotherapy of carboplatin and paclitaxel for advanced\/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses","volume":"136","author":"Nakano","year":"2016","journal-title":"Acta Otolaryngol"},{"key":"2024031106211436500_ref154","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hed.24933","article-title":"Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and\/or metastatic salivary gland cancer of the head and neck","volume":"40","author":"Hong","year":"2018","journal-title":"Head Neck"},{"key":"2024031106211436500_ref155","first-page":"719","article-title":"A single-arm, prospective, phase II study of cisplatin plus weekly docetaxel as first-line therapy in patients with metastatic or recurrent salivary gland","volume":"54","author":"Kim","year":"2022","journal-title":"Cancer"},{"key":"2024031106211436500_ref156","first-page":"3781","article-title":"Paclitaxel and carboplatin for recurrent salivary gland malignancies","volume":"20","author":"Airoldi","year":"2000","journal-title":"Anticancer Res"},{"key":"2024031106211436500_ref157","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jjco\/hyu016","article-title":"A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel","volume":"44","author":"Sonobe","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"2024031106211436500_ref158","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000112","article-title":"Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): a final report on 60 cases","volume":"40","author":"Airoldi","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"2024031106211436500_ref159","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1038\/onc.2013.348","article-title":"Aberrantly activated AREG\u2013EGFR signaling is required for the growth and survival of CRTC1\u2013MAML2 fusion-positive mucoepidermoid carcinoma cells","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"key":"2024031106211436500_ref160","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-05-1125","article-title":"Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP\/CREB regulated genes","volume":"65","author":"Coxon","year":"2005","journal-title":"Cancer Res"},{"key":"2024031106211436500_ref161","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref162","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12105-011-0302-y","article-title":"Expression of the vascular endothelial growth factor and angiopoietins in mucoepidermoid carcinoma of salivary gland","volume":"6","author":"Demasi","year":"2012","journal-title":"Head Neck Pathol"},{"key":"2024031106211436500_ref163","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<429::AID-PATH495>3.0.CO;2-1","article-title":"Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours","volume":"178","author":"Myoken","year":"1996","journal-title":"J Pathol"},{"key":"2024031106211436500_ref164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/wjon1412","article-title":"Advances in the treatment of mucoepidermoid carcinoma","volume":"13","author":"Sama","year":"2022","journal-title":"World J Oncol"},{"key":"2024031106211436500_ref165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-3-031-23175-9_20","volume-title":"Critical Issues in Head and Neck Oncology","author":"Vathiotis","year":"2023"},{"key":"2024031106211436500_ref166","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejca.2016.09.022","article-title":"A phase II study of sorafenib in recurrent and\/or metastatic salivary gland carcinomas: translational analyses and clinical impact","volume":"69","author":"Locati","year":"2016","journal-title":"Eur J Cancer"},{"key":"2024031106211436500_ref167","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cncr.30537","article-title":"Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: a multicenter phase 2 study (Korean Cancer Study Group HN14-01)","volume":"123","author":"Kim","year":"2017","journal-title":"Cancer"},{"key":"2024031106211436500_ref168","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"2024031106211436500_ref169","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hed.23647","article-title":"Phase II study of gefitinib in patients with advanced salivary gland cancers","volume":"37","author":"Jakob","year":"2015","journal-title":"Head Neck"},{"key":"2024031106211436500_ref170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2005.06.125","article-title":"Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study","volume":"23","author":"Hotte","year":"2005","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.oraloncology.2005.12.026","article-title":"A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands","volume":"43","author":"Pfeffer","year":"2007","journal-title":"Oral Oncol"},{"key":"2024031106211436500_ref172","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/annonc\/mdv537","article-title":"Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors","volume":"27","author":"Wong","year":"2016","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref173","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdr522","article-title":"A phase II study of sunitinib in recurrent and\/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC","volume":"23","author":"Chau","year":"2012","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref174","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.6086","article-title":"PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R\/M) salivary gland carcinoma (SGC)","volume":"34","author":"Guigay","year":"2016","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref175","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.6096","article-title":"Phase II study of regorafenib in progressive, recurrent\/metastatic adenoid cystic carcinoma","volume":"34","author":"Ho","year":"2016","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref176","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2021.10.033","article-title":"Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and\/or metastatic salivary gland cancer","volume":"161","author":"Boxtel","year":"2022","journal-title":"Eur J Cancer"},{"key":"2024031106211436500_ref177","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.18.01859","article-title":"Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref178","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/cncr.32754","article-title":"Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: activity and quality of life","volume":"126","author":"Locati","year":"2020","journal-title":"Cancer"},{"key":"2024031106211436500_ref179","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hed.23577","article-title":"Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck","volume":"37","author":"Thomson","year":"2015","journal-title":"Head Neck"},{"key":"2024031106211436500_ref180","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdw287","article-title":"A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma","volume":"27","author":"Ho","year":"2016","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref181","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/hed.25891","article-title":"Phase II trial with axitinib in recurrent and\/or metastatic salivary gland cancers of the upper aerodigestive tract","volume":"41","author":"Locati","year":"2019","journal-title":"Head Neck"},{"key":"2024031106211436500_ref182","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1158\/1078-0432.CCR-21-1061","article-title":"Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref183","doi-asserted-by":"crossref","first-page":"17588359211013626","DOI":"10.1177\/17588359211013626","article-title":"Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study","volume":"13","author":"Zhu","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"2024031106211436500_ref184","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00280-023-04534-7","article-title":"Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor","volume":"91","author":"Jang","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024031106211436500_ref185","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.29401","article-title":"Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma","volume":"121","author":"Keam","year":"2015","journal-title":"Cancer"},{"key":"2024031106211436500_ref186","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/1078-0432.CCR-16-2942","article-title":"A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma","volume":"23","author":"Dillon","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref187","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hed.23664","article-title":"Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: results of a phase II clinical trial","volume":"37","author":"Hoover","year":"2015","journal-title":"Head Neck"},{"key":"2024031106211436500_ref188","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.6039","article-title":"Alliance A091104: a phase II trial of MK-2206 in patients (pts) with progressive, recurrent\/metastatic adenoid cystic carcinoma","volume":"33","author":"Ho","year":"2015","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref189","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1186\/1471-2407-14-795","article-title":"A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"key":"2024031106211436500_ref190","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1158\/1078-0432.CCR-05-0241","article-title":"Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref191","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1002\/cncr.25852","article-title":"A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)","volume":"117","author":"Argiris","year":"2011","journal-title":"Cancer"},{"key":"2024031106211436500_ref192","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","article-title":"Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors","volume":"35","author":"Ferrarotto","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref193","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.6046","article-title":"Results of ACCURACY: a phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent\/metastatic (R\/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut)","volume":"40","author":"Ferrarotto","year":"2022","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref194","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10637-019-00739-x","article-title":"Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma","volume":"38","author":"Even","year":"2020","journal-title":"Invest New Drugs"},{"key":"2024031106211436500_ref195","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/2767-9764.CRC-23-0333","article-title":"A phase 1 study of the pan-Notch inhibitor CB-103 for patients with advanced adenoid cystic carcinoma and other tumors","volume":"3","author":"Hanna","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2024031106211436500_ref196","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/annonc\/mdy171","article-title":"A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors","volume":"29","author":"Ferrarotto","year":"2018","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref197","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.3390\/cancers14153691","article-title":"Rearrangements, expression, and clinical significance of MYB and MYBL1 in adenoid cystic carcinoma: a multi-institutional study","volume":"14","author":"Persson","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024031106211436500_ref198","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ebiom.2017.05.027","article-title":"Nuclear factor I\/B: a master regulator of cell differentiation with paradoxical roles in cancer","volume":"22","author":"Becker-Santos","year":"2017","journal-title":"EBioMedicine"},{"key":"2024031106211436500_ref199","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20180939","article-title":"Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma","volume":"215","author":"Mandelbaum","year":"2018","journal-title":"J Exp Med"},{"key":"2024031106211436500_ref200","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105366","article-title":"A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma","volume":"119","author":"Hanna","year":"2021","journal-title":"Oral Oncol"},{"key":"2024031106211436500_ref201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/jnci\/djad062","article-title":"Inverse agonists of retinoic acid receptor\/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma","volume":"115","author":"Viragova","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2024031106211436500_ref202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aam7304","article-title":"The cancer epigenome: concepts, challenges, and therapeutic opportunities","volume":"355","author":"Dawson","year":"2017","journal-title":"Science"},{"key":"2024031106211436500_ref203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-023-01452-6","article-title":"Clinical advances in epigenetic therapies for lymphoma","volume":"15","author":"Rosenthal","year":"2023","journal-title":"Clin Epigenetics"},{"key":"2024031106211436500_ref204","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2010.30.2307","article-title":"Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref205","doi-asserted-by":"crossref","first-page":"32918","DOI":"10.18632\/oncotarget.16464","article-title":"A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma","volume":"8","author":"Goncalves","year":"2017","journal-title":"Oncotarget"},{"key":"2024031106211436500_ref206","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","article-title":"A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer","volume":"26","author":"Rodriguez","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref207","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-21-0238","article-title":"Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2024031106211436500_ref209","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/BST20221147","article-title":"Effectors and effects of arginine methylation","volume":"51","author":"Wang","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"2024031106211436500_ref210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.36401\/JIPO-22-1","article-title":"Protein Arginine Methyltransferase 5 (PRMT5) inhibitors in oncology clinical trials: a review","volume":"5","author":"Feustel","year":"2022","journal-title":"J Immunother Precis Oncol"},{"key":"2024031106211436500_ref211","doi-asserted-by":"crossref","first-page":"S746","DOI":"10.1016\/j.annonc.2022.07.585","article-title":"456MO METEOR-1: a phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors","volume":"33","author":"Postel-Vinay","year":"2022","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref212","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-23-0092","article-title":"Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors","volume":"29","author":"Vieito","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref213","doi-asserted-by":"crossref","first-page":"P039","DOI":"10.1158\/1535-7163.TARG-21-P039","article-title":"Abstract P039: a phase 1 dose escalation study of protein arginine methyltransferase 5 (PRMT5) inhibitor PRT543 in patients with advanced solid tumors and lymphoma","volume":"20","author":"McKean","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2024031106211436500_ref214","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s12105-021-01325-5","article-title":"Trophoblast cell surface antigen 2 (Trop-2) protein is highly expressed in salivary gland carcinomas and represents a potential therapeutic target","volume":"15","author":"Wolber","year":"2021","journal-title":"Head Neck Pathol"},{"key":"2024031106211436500_ref215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000522206","article-title":"Trophoblast cell surface antigen 2 expression in human tumors: a tissue microarray study on 18,563 tumors","volume":"89","author":"Dum","year":"2022","journal-title":"Pathobiology"},{"key":"2024031106211436500_ref216","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref217","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12885-020-06847-9","article-title":"Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck","volume":"20","author":"Klein Nulent","year":"2020","journal-title":"BMC Cancer"},{"key":"2024031106211436500_ref218","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1007\/s00259-021-05433-w","article-title":"PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports","volume":"48","author":"Uijen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024031106211436500_ref219","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/1078-0432.CCR-23-0514","article-title":"Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors","volume":"29","author":"Sousa","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2024031106211436500_ref220","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/annonc\/mdx399","article-title":"Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies","volume":"28","author":"Ross","year":"2017","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref221","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/annonc\/mdw689","article-title":"Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations","volume":"28","author":"Wang","year":"2017","journal-title":"Ann Oncol"},{"key":"2024031106211436500_ref222","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103592","article-title":"Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies","volume":"170","author":"Witte","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024031106211436500_ref223","doi-asserted-by":"crossref","first-page":"750","DOI":"10.21037\/atm-20-3433","article-title":"Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2024031106211436500_ref224","doi-asserted-by":"crossref","first-page":"1611164","DOI":"10.3389\/pore.2023.1611164","article-title":"PD-1 and PD-L1 expression in rare lung tumors","volume":"29","author":"Gyulai","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"2024031106211436500_ref225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2020.08.018","article-title":"A randomized phase 2 study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma","volume":"109","author":"Mahmood","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024031106211436500_ref226","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1200\/JCO.2019.37.15_suppl.6083","article-title":"NISCAHN: a phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent\/metastatic (R\/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group","volume":"37","author":"Fayette","year":"2019","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref227","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-023-02518-x","article-title":"Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial","author":"Vos","year":"2023","journal-title":"Nat Med"},{"key":"2024031106211436500_ref228","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.22.02221","article-title":"Phase II clinical trial of axitinib and avelumab in patients with recurrent\/metastatic adenoid cystic carcinoma","volume":"41","author":"Ferrarotto","year":"2023","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref229","doi-asserted-by":"crossref","first-page":"suppl6048","DOI":"10.1200\/JCO.2023.41.16_suppl.6048","article-title":"A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent\/metastatic adenoid cystic carcinoma","volume":"41","author":"Mohamadpour","year":"2023","journal-title":"J Clin Oncol"},{"key":"2024031106211436500_ref230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12672-022-00502-4","article-title":"Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case","volume":"13","author":"Farhat","year":"2022","journal-title":"Discov Oncol"},{"key":"2024031106211436500_ref231","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.adg9652","article-title":"Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS","volume":"381","author":"Schulze","year":"2023","journal-title":"Science"},{"key":"2024031106211436500_ref232","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","article-title":"The Notch signaling pathway: a potential target for cancer immunotherapy","volume":"16","author":"Li","year":"2023","journal-title":"J Hematol Oncol"},{"key":"2024031106211436500_ref233","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-023-06511-9","article-title":"CD300ld on neutrophils is required for tumour-driven immune suppression","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"2024031106211436500_ref234","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-023-01456-y","article-title":"The artificial intelligence and machine learning in lung cancer immunotherapy","volume":"16","author":"Gao","year":"2023","journal-title":"J Hematol Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/3\/229\/56912489\/hyad160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/3\/229\/56912489\/hyad160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T07:52:57Z","timestamp":1730706777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/54\/3\/229\/7453424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":234,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,11,28]]},"published-print":{"date-parts":[[2024,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyad160","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,28]]}}}